CClinicalTrials.gg
CompletedNCT04169425Updated Nov 21, 2019

Laparoscopic Surgery of Rectal Cancer and Ileostomy

An observational study in Ileostomy - Stoma, Ileostomy; Complications and Leakage, Anastomotic, sponsored by Campus Bio-Medico University. Completed. Open to participants aged 67 Years to 86 Years. Per ClinicalTrials.gov, last updated 2019-11-21.

Sponsored by Campus Bio-Medico University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
150
Ages
67 Years to 86 Years
Sex
All
01

Study summary

Elective diverting ileostomy may reduce consequences of anastomotic failure in laparoscopic TME. Aiming to evaluate the effectiveness of elective diverting ileostomy, its impact on the incidence and clinical behavior of anastomotic leakage and the complications related to its presence and take down were analyzed.

Read the detailed description

From a prospective collected database, data regarding patients who underwent to laparoscopic TME, with (Group 1) or without (Group 2) elective diverting ileostomy for rectal cancer from 2012 to 2017 at University Campus Bio-Medico di Roma, have been retrospectively analyzed.

02

Conditions studied

  • Ileostomy - Stoma
  • Ileostomy; Complications
  • Leakage, Anastomotic

Browse trials for

03

In context

Anastomotic Leak

209 studies on the registry are indexed under Anastomotic Leak; 60 are open to participants now.

This study's enrollment of 150 is below the median of 200 across 108 observational studies indexed under Anastomotic Leak.

Browse Anastomotic Leak studies →

Lead sponsor

Campus Bio-Medico University is the lead sponsor of 82 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
67 Years to 86 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who underwent to laparoscopic TME, for rectal cancer from 2012 to 2017 at University Campus Bio-Medico di Roma.

Inclusion criteria

  • adult patients (aged 18 years and over)
  • patients submitted to elective Anterior Rectal Resection

Exclusion criteria

Exclusion Criteria:

  • chronic use of immunosuppressant agents
  • urgent surgery
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
150 participants (actual)
Patient registry
No

Groups and cohorts

  • Group 1

    patients who underwent to laparoscopic TME, with elective diverting ileostomy for rectal cancer

    Procedure: elective diverting ileostomy

  • Group 2

    patients who underwent to laparoscopic TME, without elective diverting ileostomy for rectal cancer

Interventions

  • Procedureelective diverting ileostomy
06

What researchers measure

Primary outcomes

  1. Number of participants with anastomotic leakage

    Leakage was defined on the basis of perianastomotic drain appearance and/or of radiological findings during postoperative X-Ray or abdominal CT scan enema

    Time frame: 90 days

Secondary outcomes

  1. Number of participants with post-operative complications

    post-operative complication in patients submitted to Anterior Rectal Resection

    Time frame: 90 days

  2. Number of participants with fever Surgical site infection Abdominal collections Anastomotic leakage Anastomotic bleeding Perforation Anastomotic stenosis Number of participants with fever

    post-operative fever in patients submitted to Anterior Rectal Resection

    Time frame: 90 days

  3. Number of participants with surgical site infection

    post-operative surgical site infection in patients submitted to Anterior Rectal Resection

    Time frame: 90 days

  4. Number of participants with abdominal collections

    post-operative abdominal collections in patients submitted to Anterior Rectal Resection

    Time frame: 90 days

  5. Number of participants with anastomotic bleeding

    post-operative anastomotic bleeding in patients submitted to Anterior Rectal Resection

    Time frame: 90 days

  6. Number of participants with perforation

    post-operative perforation in patients submitted to Anterior Rectal Resection

    Time frame: 90 days

  7. Number of participants with anastomotic stenosis

    post-operative anastomotic stenosis in patients submitted to Anterior Rectal Resection

    Time frame: 90 days

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04169425
Lead sponsor
Campus Bio-Medico University
Responsible party
Vincenzo La Vaccara (Principal Investigator, Campus Bio-Medico University) — Principal investigator
First posted
Nov 19, 2019
Start date
Jan 2, 2012
Primary completion
Dec 22, 2017
Completion
Feb 1, 2018
Last update
Nov 21, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion